September, 2019 | Edelman & Edelman, P.C.

FDA: Heartburn drug Zantac may contain cancer-causing substance

On Behalf of Edelman & Edelman, P.C. | Sep 22, 2019 | Pharmaceutical Liability

Do you take the heartburn drug Zantac or its generic equivalent, ranitidine? If so, you might want to switch brands. The U.S. Food and Drug Administration has announced that it found a cancer-causing contaminant in samples of ranitidine. However, it only found the...

What does New York’s new statute of limitations for sex abuse mean?

On Behalf of Edelman & Edelman, P.C. | Sep 17, 2019 | Sexual Abuse

Being sexually abused is traumatizing, and that trauma often causes victims to suppress the memory of what happened until they are psychologically able to deal with it. That can take years, in some cases. That’s why it’s so important that New York passed the Child...

Opioid litigation against major pharmaceutical companies heats up

On Behalf of Edelman & Edelman, P.C. | Sep 16, 2019 | Pharmaceutical Liability

In a landmark case late last month, a court in Oklahoma found that Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, had created a public nuisance by flooding the market with oxycodone, fentanyl and other opioids. Johnson & Johnson had fanned...

What are New York City’s most dangerous intersections for bikers?

On Behalf of Edelman & Edelman, P.C. | Sep 10, 2019 | Bicycle Accidents

The intersection of West 23rd Street and Sixth Avenue in Chelsea is the most dangerous intersection in New York City for bikers, according to a report by the website Localize.city. You may remember an incident in June where a 20-year-old bike messenger was struck and...